HTLV type I/II in British Columbia Amerindians: A seroprevalence study and sequence characterization of an HTLV type IIa isolate

AIDS Research and Human Retroviruses

Volumn 16, Issue 9, 2000, Pages 883-892

  Peters, Andrew A ^a,b   Coulthart, Michael B ^c   Oger, Joel J F ^d   Waters, David J ^e   Crandall, Keith A ^f   Baumgartner, Alexandra A ^a   Ward, Ryk H ^g   Dekaban, Gregory A ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Bureau of Microbiology   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e NATIONAL CANCER INSTITUTE   (United States)

^f BRIGHAM YOUNG UNIVERSITY   (United States)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAX PROTEIN;

ARTICLE; CANADA; CONTROLLED STUDY; GENE POOL; GENE SEQUENCE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; INTRAVENOUS DRUG ABUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEROPREVALENCE; SEXUAL TRANSMISSION; UNINDEXED SEQUENCE; VIRUS ISOLATION; VIRUS TRANSMISSION;

BASE SEQUENCE; BRITISH COLUMBIA; DNA, VIRAL; EVOLUTION, MOLECULAR; GENES, PX; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE HOMOLOGY, NUCLEIC ACID; SEROEPIDEMIOLOGIC STUDIES; TERMINAL REPEAT SEQUENCES;

EID: 0034631430     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050042828     Document Type: Article

References (43)

1. 1. Suzuki Y and Gojobori T: The origin and evolution of human T-cell lymphotropic virus types I and II. Virus Genes 1998;16:69-84.
2. 2. Ijichi S, Matsuda T, Maruyama I, Izumihara T, Kojima K, Niimura T, Maruyama Y, Sonoda S, Yoshida A, and Osame M: Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis 1990;49:718-721.
3. 3. Kitajima I, Yamamoto K, Sato K, Nakajima Y, Nakajima T, Maruyama I, Osame M, and Nishioka K: Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J Clin Invest 1991;88:1315-1322.
4. 4. Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, and Ross G: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645-646.
5. 5. Blattner WA and Gallo RC: The epidemiology of HTLV-I and HTLV-II infection. In: Adult T-Cell Leukemia (Takatsuki K, ed.). Oxford Medical Publications, Oxford, 1994, pp. 45-90.
6. 6. Pardi D, Hjelle B, Folks TM, and Lal RB: Genotypic characteristics of HTLV-II isolates from Amerindian and non-Indian populations. Virus Genes 1995;10:27-35.
7. 7. Lowis GW, Sheremata WA, Wickman PR, Dube S, Dube DK, and Poiesz BJ: HTLV-II risk factors in Native Americans in Florida. Neuroepidemiology 1999;18:37-47.
8. 8. Picard FJ, Coulthart MB, Oger J, King EE, Kim S, Arp J, Rice GPA, and Dekaban GA: Human T-lymphotropic virus type I (HTLV-I) in coastal natives of British Columbia: Phylogenetic affinities and possible origins. J Virol 1995;69:7248-7256.
9. 9. Oger JJF, Werker H, Foti DJ, and Dekaban GA: HTLV-I associated myelopathy: An endemic disease of Canadian aboriginals of the northwest Pacific coast? Can J Neuro Sci 1993;20:302-306.
10. 10. Dekaban GA, Oger JJF, Foti D, King EE, Waters DJ, Picard FJ, Arp J, Werker D, and Rice GPA: HTLV-I infection associated with disease in aboriginal Indians from British Columbia: A serological and PCR analysis. Clin Diagn Virol 1994;2:67-78.
11. 11. Gascoyne RD, Kim SM, Oger JJ, Melosky BL, and Dekaban GA: HTLV-I associated adult T cell leukemia/lymph oma: Report of two cases from an Amerindian population in coastal northwest British Columbia. Leukemia 1996;10:552-557.
12. 12. Cleghorn FR, Manns A, Falk R, Harte P, Hanchard B, Jack N, Williams E, Jaffe E, White F, Bartholomew C, and Blattner W: Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. J Natl Can Inst 1995;87: 1009-1014.
13. 13. Kaplan JE, Osame M, Kubota H, Nishitani H, Maeda Y, Khabbaz RF, and Janssen R: The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990;3:1096-1101.
14. 14. Ward RH, Redd A, Valencia D, Frazier B, and Pääbo S: Genetic and linguistic differentiation in the Americas. Proc Natl Acad Sci USA 1993;90:10633-10637.
15. 15. Atkins C, Reuffel L, Roddy J, Platts M, Robinson H, and Ward R: Rheumatic disease in the Nuu-Chah-Nulth native Indians of the Pacific Northwest. J Rheumatol 1988;15:684-690.
16. 16. Sheremata WA, Harrington WJ Jr, Bradshaw PA, Foung SKH, Raffanti SP, Berger JR, Snodgrass S, Resnick L, and Poiesz BJ: Association of "(tropical) ataxic neuropathy" with HTLV-II. Virus Res 1993;29:71-77.
17. 17. Peters AA, Oger JJF, Coulthart MB, Waters DJ, Cummings HJ, and Dekaban GA: An apparent case of human T-cell lymphotropic virus type II (HTLV-II)-associated neurological disease: A clinical, molecular, and phylogenetic characterisation. J Clin Virol 1999;14:37-50.
18. 17a. Huelsenbeck JP and Crandall KA: Phylogeny estimation and hypothesis testing using maximum likelihood. Ann Rev Ecol Syst 1997;28:437-466.
19. 18. Felsenstein J: PHYLIP (Phylogeny Inference Package), version 3.572c. Department of Genetics, University of Washington, Seattle, 1993.
20. * and Other Methods). Sinauer Associates, Sunderland, Massachusetts, 1999.
21. 20. Jukes TH and Cantor CR: Evolution of protein molecules. In: Mammalian Protein Metabolism (Munro HN, ed.). Academic Press, New York, 1969, pp. 21-123.
22. 21. Felsenstein J: Evolutionary trees from DNA sequences: A maximum likelihood approach. Mol Biol Evol 1981;17:368-376.
23. 22. Felsenstein J: Confidence limits on phylogenies: An approach using the bootstrap. Evolution 1985;39:783-791.
24. 23. Posada D and Crandall KA: MODELTEST: Testing the model of DNA substitution. Bioinformatics 1998;14:817-818.
25. 24. Templeton AR, Crandall KA, and Sing CF: A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping and DNA sequence data. III. Cladogram estimation. Genetics 1992;132:619-633.
26. 25. Crandall KA: Intraspecific phylogenetics: Support for dental transmission of human immunodeficiency virus. J Virol 1995;69: 2351-2356.
27. 26. Crandall KA: Multiple interspecies transmissions of human and simian T-cell leukemia/lymphoma virus type I sequences. Mol Biol Evol 1996;13:115-131.
28. 27. Crandall KA: Intraspecific cladogram estimation: Accuracy at higher levels of divergence. Syst Biol 1994;43:222-235.
29. 28. Eiraku N, Monken C, Kubo T, Zhu SW, Rios M, Bianco C, Hjelle B, Nagashima K, and Hall WW: Nucleotide sequence and restriction fragment length polymorphism analysis of the long terminal repeat of human T cell lymphotropic virus type II. AIDS Res Hum Retroviruses 1995;11:625-636.
30. 29. Switzer WM, Pieniazek D, Swanson P, Samdal HH, Soriano V, Khabbaz RF, Kaplan JE, Lal RB, and Heneine W: Phylogenetic relationship and geographic distribution of multiple human t-cell lymphotropic virus type II subtypes. J Virol 1995;69:621-632.
31. 30. Eiraku N, Novoa P, da Costa Ferreira M, Monken C, Ishak R, da Costa Ferreira O, Zhu SW, Lorenco R, Ishak M, Azevedo V, Guerreiro JF, Pombo de Oliveira M, Loureiro P, Hammershlak N, Ijichi S, and Hall WW: Identification and characterization of a new and distinct subtype of human T-cell lymphotropic virus type 2. J Virol 1996;70:1481-1492.
32. 31. Lal RB, Pardi D, Switzer W, Segurado A, and Black F: Immune reactivity of HTLV-IIa-infected Kayapo Indians with HTLV-IIb extended Tax epitope. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:476-477.
33. 32. Hasegawa M, Kishino K, and Yano T: Dating the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 1985;22:160-174.
34. 32a. Tamura K and Nei M: Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 1993;10:512-526.
35. 32b. Kimura M: Estimation of evolutionary distances between homologous nucleotide sequences. Proc Natl Acad Sci USA 1981;78: 454-458.
36. 33. Yang Z: Among-site rate variation and its impact on phylogenetic analyses. Trends Ecol Evol 1996;11:367-372.
37. 34. Salemi M, Vandamme AM, Gradozzi C, Van LK, Cattaneo E, Taylor G, Casoli C, Goubau P, Desmyter J, and Bertazzoni U : Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug users. J Mol Evol 1998;46:602-611.
38. 35. Egan JF, O'Leary B, Lewis MJ, Mulcahy F, Sheehy N, Hasegawa H, Fitzpatrick F, O'Connor JJ, O'Riordan J, and Hall WW: High rate of human T lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland. AIDS Res Hum Retroviruses 1999;15:699-705.
39. 36. Ishak R, Harrington WJ, Azevedo VN, Eiraku N, Ishak MOG, Guerreiro JF, Santos SB, Kubo T, Monken C, Alexander S, and Hall WW: Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil. AIDS Res Hum Retroviruses 1995;11:813-821.
40. 37. Fujiyoshi T, Li HC, Lou H, Yashiki S, Karino S, Zaninovic V, Oneegllo SG, Camacho M, Andrade R, Hurtado LV, Gomez LH, Damiani E, Cartier L, Dipierri JE, Hayami M, Sonoda S, and Tajima K: Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America. AIDS Res Hum Retroviruses 1999;15:1235-1239.
41. 38. Neel JV, Biggar RJ, and Sukernik RI: Virologic and genetic studies relate Amerind origins to the indigenous people of the Mongolia/Manchuria/southeastern Siberia region. Proc Natl Acad Sci USA 1994;91:10737-10741.
42. 39. Miura K, Yamashita M, Zaninovic V, Cartier L, Takehisa J, Igarashi T, Ido E, Fujiyoshi T, Sonoda S, Tajima K, and Hayami M: Molecular phylogeny of human T-cell leukemia virus type I and II of Amerindians in Colombia and Chile. J Mol Evol 1997;44:S76-S82.
43. 40. Salemi M, Lewis M, Egan JF, Hall WW, Desmyter J, and Vandamme AM: Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes. Proc Natl Acad Sci USA 1999;96: 13253-13258.